The Rising Tide of Cancer in Later Generations: Beyond Colorectal Trends

For several years, headlines have warned of a mysterious rise in colorectal cancer (CRC) among young people. The discourse usually centers on a search for a single "smoking gun"—be it ultra-processed foods, microplastics, the microbiome, or sedentary lifestyles. However, when the data is analyzed through the lens of birth cohorts rather than static age brackets, a more complex and concerning picture emerges.

Moving Beyond the "Young People" Narrative

When we say CRC is increasing in "young people," the terminology is often imprecise. Most medical data is presented in age bands (e.g., the rate for 20-25 year olds in 1995 vs. 2022). This can be misleading because it doesn't track the same group of people as they age; it simply looks at whoever happens to be in that age bracket at a specific time.

By digitizing and replotting data from studies like Downham et al. (2026), a different trend becomes clear. Between 1920 and 1950, later generations generally enjoyed lower CRC rates across all phases of their lives. However, starting between 1950 and 1960, this pattern reversed. Since then, later generations have shown higher CRC rates at all ages compared to those born before them.

This suggests that the risk isn't just shifting to a younger demographic; rather, people born in later cohorts are facing a higher baseline risk of colorectal cancer throughout their entire lifespan.

A Systemic Increase Across Multiple Cancers

Colorectal cancer is the primary focus of public conversation, but it is not an isolated phenomenon. Data from Sung et al. (2019) indicates that various other cancers are also rising in later generations, including:

  • Uterine
  • Gallbladder
  • Kidney
  • Liver
  • Pancreas
  • Thyroid

CRC receives the most attention because it occupies a unique intersection of risk and utility: it is common and dangerous, yet highly detectable via screening and treatable if caught early. While thyroid cancer rates have also skyrocketed, the clinical benefit of early detection is less clear. Conversely, pancreatic cancer is rising but lacks an effective screening mechanism. CRC is the "perfect storm" for public health messaging because telling people to get screened actually saves lives.

The Search for Causality

Experts remain divided on the cause of this generational shift. Several hypotheses have been proposed, though many lack definitive longitudinal evidence:

  • Metabolic Health: Obesity, diabetes, and insulin resistance leading to chronic inflammation.
  • Dietary Factors: Ultra-processed foods and emulsifiers degrading colon mucus, or high red meat consumption exposing the colon to nitrites.
  • The Microbiome: The emergence of genotoxic strains of E. coli that produce colibactin. As noted by community contributors, DNA sequencing of cancer mutations provides strong clues about mutagens, and some 2025 research suggests colibactin may be a significant driver of early-onset CRC.
  • Environmental Exposures: PFAS ("forever chemicals"), microplastics, and endocrine disruptors.

The Critical Role of Screening

Because CRC is treatable when caught early, the conversation inevitably turns to screening. The community discussion highlights several key practical considerations:

Prevention vs. Detection

Colonoscopies are not merely diagnostic; they are preventative. Physicians can identify and remove pre-cancerous polyps during the procedure, stopping cancer before it starts. One user shared a poignant example: "I had bleeding for over a year... 36 polyps were found. If I had waited until the screening age, I would have had high chances of cancer."

Overcoming the "Too Young" Barrier

There is a tension between medical protocols and individual risk. Many patients report that doctors are reluctant to order screenings for asymptomatic patients who fall below the standard age threshold. This creates a gap where detectable, treatable risks are ignored purely for cost or protocol reasons. As one contributor noted, the only long-term solution may be making screening so affordable and automated that it can be performed based on individual risk tolerance rather than arbitrary age cut-offs.

Weighing the Risks

While screening is highly recommended, it is not without risk. Concerns regarding general anesthesia and the potential for botched procedures are valid, though many patients describe the process as a "piece of cake" once the prep is complete. For those hesitant about invasive procedures, stool tests (like Cologuard) offer an alternative, though they typically require more frequent repetition than a colonoscopy.

Conclusion

The rise of colorectal cancer is not a quirk of youth, but a symptom of a broader trend affecting later generations across multiple cancer types. While the exact cause remains elusive, the actionable reality is clear: early detection is the most effective tool available. Whether through dietary changes, microbiome health, or clinical screening, the goal is to move the needle from late-stage intervention to early prevention.

Sources